These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12875966)

  • 21. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
    Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
    Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
    Wang H; Zhang Y; Heuckeroth RO
    FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture.
    Xu Z; Castellino FJ; Ploplis VA
    Blood; 2010 Mar; 115(10):2038-47. PubMed ID: 20009036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PAI-1 in tissue fibrosis.
    Ghosh AK; Vaughan DE
    J Cell Physiol; 2012 Feb; 227(2):493-507. PubMed ID: 21465481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.
    Ghosh AK; Bradham WS; Gleaves LA; De Taeye B; Murphy SB; Covington JW; Vaughan DE
    Circulation; 2010 Sep; 122(12):1200-9. PubMed ID: 20823384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.
    Matsuoka H; Sisson TH; Nishiuma T; Simon RH
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):705-13. PubMed ID: 16840775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model.
    Oh CK; Ariue B; Alban RF; Shaw B; Cho SH
    Biochem Biophys Res Commun; 2002 Jun; 294(5):1155-60. PubMed ID: 12074598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
    Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF
    J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H; Vohra BP; Zhang Y; Heuckeroth RO
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
    Oikawa T; Freeman M; Lo W; Vaughan DE; Fogo A
    Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.
    Lemaire R; Burwell T; Sun H; Delaney T; Bakken J; Cheng L; Rebelatto MC; Czapiga M; de-Mendez I; Coyle AJ; Herbst R; Lafyatis R; Connor J
    Arthritis Rheumatol; 2016 Feb; 68(2):473-83. PubMed ID: 26414805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis.
    Flevaris P; Vaughan D
    Semin Thromb Hemost; 2017 Mar; 43(2):169-177. PubMed ID: 27556351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor type-1 deficiency attenuates murine antigen-induced arthritis.
    Van Ness K; Chobaz-Péclat V; Castellucci M; So A; Busso N
    Rheumatology (Oxford); 2002 Feb; 41(2):136-41. PubMed ID: 11886960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.
    Pant A; Kopec AK; Baker KS; Cline-Fedewa H; Lawrence DA; Luyendyk JP
    Am J Pathol; 2018 May; 188(5):1204-1212. PubMed ID: 29454747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
    Olman MA; Mackman N; Gladson CL; Moser KM; Loskutoff DJ
    J Clin Invest; 1995 Sep; 96(3):1621-30. PubMed ID: 7544811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
    Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D
    Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.
    Huang WT; Vayalil PK; Miyata T; Hagood J; Liu RM
    Am J Respir Cell Mol Biol; 2012 Jan; 46(1):87-95. PubMed ID: 21852684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury.
    Abderrahmani R; François A; Buard V; Benderitter M; Sabourin JC; Crandall DL; Milliat F
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):942-8. PubMed ID: 19480973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma.
    Matsushita M; Yamamoto T; Nishioka K
    Clin Exp Immunol; 2005 Mar; 139(3):429-38. PubMed ID: 15730388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.